Markets
MET

Company News for December 6, 2011 - Corporate Summary

An image of a stock chart
Credit: Shutterstock photo

• Shares of bio-pharma company Affymax Inc. (NASDAQ: AFFY ) increased 19.24% after FDA found Affymax's experimental anemia medication is as effective as drugs by Amgen, Inc. (NASDAQ: AMGN )

• Discovery Group LLC announced it had acquired a 5.8% stake in software maker Intralinks Holdings Inc. (NYSE: IL ). Following this development, shares of Intralinks Holdings gained 9.63% to close at $5.69

• Share prices of web-based software company SuccessFactors Inc. (NYSE: SFSF ) sky rocketed 51.43% after SAP AG (NYSE: SAP ) said it would buy the company in a deal worth $3.4 billion

• Pharma company Regeneron Pharmaceuticals Inc.'s (NASDAQ: REGN ) share prices fell 5.53% after a study found no major difference between its Eylea medicine and a Roche Holding AG drug to treat an eye disorder

• U.S. life insurance company MetLife, Inc. (NYSE: MET ) said earnings will probably rise in 2012 as CEO Steven Kandarian modifies management a year after the firm's biggest takeover

AFFYMAX INC ( AFFY ): Free Stock Analysis Report

INTRALINKS HLDG ( IL ): Free Stock Analysis Report

METLIFE INC ( MET ): Free Stock Analysis Report

REGENERON PHARM ( REGN ): Free Stock Analysis Report

SAP AG ADR ( SAP ): Free Stock Analysis Report

SUCCESSFACTORS (SFSF): Free Stock Analysis Report

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MET AFFY REGN SAP

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More